Navigation Links
DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis
Date:8/26/2009

DENVER, Aug. 26 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that it will present three abstracts at the 3rd North American Chapter meeting of the International Society for Peritoneal Dialysis (ISPD) on August 27-29 in Vancouver, British Columbia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

ISPD provides leading renal health care providers with the opportunity to advance their knowledge of peritoneal dialysis (PD) and to promote advancement of such knowledge through international meetings and scientific publications.

The presentations will highlight subjects critical to physicians, nurses and other practitioners in the field of PD, including:

  • A DaVita(R) pilot program evaluating ESA use in PD patients and how to ensure patient adherence while maintaining hemoglobin outcomes;
  • Access to Peritoneal Dialysis: Overcoming Obstacles for Uninsured, Unencountered Patients - a look at how changes in PD clinic infrastructure and the industry's perception would increase usage of this valuable treatment method;
  • The Post-Peritonitis Checklist: Beyond Pharmacological Treatment - an analysis of the impact implementing a step-by-step checklist of pre-existing and innovative interventions into patient care practices resulted in reduced peritonitis rates.

"DaVita is committed to leading the renal community in seeking out new and innovative ways to improve clinical outcomes for patients with kidney disease," said Allen R. Nissenson MD, Chief Medical Officer at DaVita. "The three abstracts being presented at this meeting reflect DaVita's success in driving quality improvement for patients."

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita has been recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Workplaces(TM). As of June 30, 2009, DaVita operated or provided administrative services at 1,493 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 116,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The City of Tacoma Announces Official DaVita Day
2. DaVita Only Dialysis Provider Named on EPAs FORTUNE 500 List of Green Power Purchasers
3. DaVita Hosts National Quality Week 2009
4. DaVita Donates Toys, Shoes and School Supplies for Army National Guard to Distribute in Iraq
5. Mayor Julian Jolly Reseueollo Dialysis Center Officially Opens Doors With Support From Bridge of Life - DaVita Medical Missions
6. Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence
7. DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
8. DaVitas Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland
9. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
10. DaVita.com Provides Easy Recipes to Plan Your Fathers Day Dinner
11. DaVita Launches First Corporate Social Responsibility Report With Nationwide Community Service Blitz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally ... the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists ... be aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice Treatment Center® booth ... 13-16, was a busy spot this year. Liz Solovay and Adrian Picheny, the ... outbreaks among camp communities during the upcoming 2017 camping season. “Lice infestations at ...
(Date:3/28/2017)... ... 2017 , ... Thank you to all who attended Capio Partners Winter 2017 ... was exclusive to providers and offered an opportunity to collaborate and network with healthcare ... Grand Hyatt where attendees gathered for a lively discussion on trends and issues that ...
(Date:3/27/2017)... ... ... New patients who have sleep apnea in Aurora, CO, can now ... Sleep apnea is often left untreated because patients are not familiar with common symptoms ... , Dr. Braasch seeks to raise awareness of sleep apnea in Aurora, CO, and ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Justin Kolnick, Kara ... by teaching their patients about the key role this treatment plays in protecting oral ... experienced endodontist. To better serve those who need a root canal in White Plains, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  BERG, a biopharmaceutical company ... research approach, today announced that the company,s ... of new data using a cold-induced model ... metabolism. Joslin Diabetes Center led the investigation ... for analysis of samples.  The findings were ...
(Date:3/27/2017)... March 27, 2017 On Friday, ... NASDAQ Composite closed the trading session up 0.19%; the ... S&P 500 was down 0.08%. US markets made broad ... the day in green. Pre-market today, Stock-Callers.com reviews these ... N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group ...
(Date:3/27/2017)... BOSTON , March 27, 2017  Allergan ... and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical ... innovative therapies based upon tetracycline chemistry, announced that ... the treatment of moderate to severe acne met ... a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with ...
Breaking Medicine Technology: